We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Malignant tissues showed moderate cytoplasmic and membranous staining. Hepatocellular carcinomas, colorectal cancers along with fractions of cases in ductal breast carcinomas, pancreatic and testicular cancers displayed strong positivity. A majority of renal cancers and several malignant lymphomas were weakly stained or negative.
GENE INFORMATION
Gene name
RGCC (HGNC Symbol)
Synonyms
bA157L14.2, C13orf15, RGC-32, RGC32
Description
Regulator of cell cycle (HGNC Symbol)
Entrez gene summary
This gene is thought to regulate cell cycle progression. It is induced by p53 in response to DNA damage, or by sublytic levels of complement system proteins that result in activation of the cell cycle. The encoded protein localizes to the cytoplasm during interphase and to centrosomes during mitosis. The protein forms a complex with polo-like kinase 1. The protein also translocates to the nucleus in response to treatment with complement system proteins, and can associate with and increase the kinase activity of cell division cycle 2 protein. In different assays and cell types, overexpression of this protein has been shown to activate or suppress cell cycle progression. [provided by RefSeq, Jul 2008]
Q9H4X1 [Direct mapping] Regulator of cell cycle RGCC
Show all
Predicted secreted proteins Secreted proteins predicted by MDSEC Phobius predicted secreted proteins SPOCTOPUS predicted secreted proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001100 [negative regulation of exit from mitosis] GO:0001937 [negative regulation of endothelial cell proliferation] GO:0003331 [positive regulation of extracellular matrix constituent secretion] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0005813 [centrosome] GO:0006956 [complement activation] GO:0008285 [negative regulation of cell proliferation] GO:0010628 [positive regulation of gene expression] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0016525 [negative regulation of angiogenesis] GO:0019901 [protein kinase binding] GO:0030295 [protein kinase activator activity] GO:0031659 [positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle] GO:0032147 [activation of protein kinase activity] GO:0032967 [positive regulation of collagen biosynthetic process] GO:0043537 [negative regulation of blood vessel endothelial cell migration] GO:0045840 [positive regulation of mitotic nuclear division] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0050710 [negative regulation of cytokine secretion] GO:0050715 [positive regulation of cytokine secretion] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051496 [positive regulation of stress fiber assembly] GO:0051726 [regulation of cell cycle] GO:0070412 [R-SMAD binding] GO:0071158 [positive regulation of cell cycle arrest] GO:0071456 [cellular response to hypoxia] GO:0071850 [mitotic cell cycle arrest] GO:0072537 [fibroblast activation] GO:0090272 [negative regulation of fibroblast growth factor production] GO:1901203 [positive regulation of extracellular matrix assembly] GO:1901991 [negative regulation of mitotic cell cycle phase transition] GO:2000048 [negative regulation of cell-cell adhesion mediated by cadherin] GO:2000353 [positive regulation of endothelial cell apoptotic process] GO:2000573 [positive regulation of DNA biosynthetic process]